Elan Ezickson - Net Worth and Insider Trading

Elan Ezickson Net Worth

The estimated net worth of Elan Ezickson is at least $9,269 dollars as of 2024-11-10. Elan Ezickson is the Chief Business Officer of AVEO Pharmaceuticals Inc and owns about 489 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $7,335. Elan Ezickson is also the Director of Marinus Pharmaceuticals Inc and owns about 5,600 shares of Marinus Pharmaceuticals Inc (MRNS) stock worth over $1,934. Details can be seen in Elan Ezickson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elan Ezickson has not made any transactions after 2023-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Elan Ezickson

Elan Ezickson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elan Ezickson owns 4 companies in total, including Alaunos Therapeutics Inc (TCRT) , Marinus Pharmaceuticals Inc (MRNS) , and Scholar Rock Holding Corp (SRRK) among others .

Click here to see the complete history of Elan Ezickson’s form 4 insider trades.

Insider Ownership Summary of Elan Ezickson

Ticker	Comapny	Transaction Date	Type of Owner
TCRT	Alaunos Therapeutics Inc	2018-09-18	director
MRNS	Marinus Pharmaceuticals Inc	2023-02-06	director
SRRK	Scholar Rock Holding Corp	2018-05-23	COO & Head of Corp Development
		2012-01-26	Chief Business Officer

Elan Ezickson Latest Holdings Summary

Elan Ezickson currently owns a total of 2 stocks. Among these stocks, Elan Ezickson owns 489 shares of AVEO Pharmaceuticals Inc (AVEO) as of January 26, 2012, with a value of $7,335 and a weighting of 79.13%. Elan Ezickson also owns 5,600 shares of Marinus Pharmaceuticals Inc (MRNS) as of February 6, 2023, with a value of $1,934 and a weighting of 20.87%.

Latest Holdings of Elan Ezickson

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AVEO	AVEO Pharmaceuticals Inc	2012-01-26	489	15.00	7,335
MRNS	Marinus Pharmaceuticals Inc	2023-02-06	5,600	0.35	1,934

Holding Weightings of Elan Ezickson

Elan Ezickson Form 4 Trading Tracker

According to the SEC Form 4 filings, Elan Ezickson has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the sale of 111 shares on January 26, 2012, which brought Elan Ezickson around $14,801.

According to the SEC Form 4 filings, Elan Ezickson has made a total of 1 transactions in Marinus Pharmaceuticals Inc (MRNS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Marinus Pharmaceuticals Inc is the sale of 750 shares on February 6, 2023, which brought Elan Ezickson around $4,920.

Insider Trading History of Elan Ezickson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Elan Ezickson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elan Ezickson Ownership Network

Ownership Network List of Elan Ezickson

No Data

Ownership Network Relation of Elan Ezickson

Elan Ezickson Owned Company Details

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Elan Ezickson is the director of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Elan Ezickson made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alaunos Therapeutics Inc Insider Transactions

No Available Data

What does Marinus Pharmaceuticals Inc do?

Who are the key executives at Marinus Pharmaceuticals Inc?

Elan Ezickson is the director of Marinus Pharmaceuticals Inc. Other key executives at Marinus Pharmaceuticals Inc include Chief Commercial Officer Christina Shafer , CFO Steven Pfanstiel , and Chief Medical Officer Joseph Hulihan .

Marinus Pharmaceuticals Inc (MRNS) Insider Trades Summary

Over the past 18 months, Elan Ezickson made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marinus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Scholar Rock Holding Corp do?

Who are the key executives at Scholar Rock Holding Corp?

Elan Ezickson is the COO & Head of Corp Development of Scholar Rock Holding Corp. Other key executives at Scholar Rock Holding Corp include Chief Commercial Officer Tracey Sacco , Chief Medical Officer Jing L. Marantz , and SVP and Head of Research Mo Qatanani .

Scholar Rock Holding Corp (SRRK) Insider Trades Summary

Over the past 18 months, Elan Ezickson made no insider transaction in Scholar Rock Holding Corp (SRRK). Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 336,643 shares made by Edward H Myles , a net sale of 35,372 shares made by Mo Qatanani , and a net sale of 13,709 shares made by Caryn Parlavecchio .

In summary, during the past 3 months, insiders sold 1,561,902 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 1,561,902 shares. During the past 18 months, 1,709,693 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,579,493 shares were bought by its insiders, resulting in a net purchase of 4,869,800 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Scholar Rock Holding Corp Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Elan Ezickson is the Chief Business Officer of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

Elan Ezickson Mailing Address

Above is the net worth, insider trading, and ownership report for Elan Ezickson. You might contact Elan Ezickson via mailing address: Aveo Pharmaceuticals, Inc., 75 Sidney Street, Cambridge Ma 02139.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.